🔎 Trials Near Me

Beranda › Kolitis Ulseratif › Missouri › St. Louis

Uji klinis Kolitis Ulseratif di St. Louis, MO

13 studi untuk Kolitis Ulseratif mencari peserta di lokasi sekitar St. Louis (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Menerima pesertaFase 2
  • Specialists In Gastroenterology /ID# 283939, St Louis
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Menerima pesertaFase 4
  • SSM Health Medical Group, Bridgeton · 15 mi jauhnya
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06581328

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Menerima pesertaFase 2
  • Site US-006, St Louis
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07845487

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

Menerima pesertaFase 2/3
  • Washington University, St Louis
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Menerima pesertaFase 3
  • Washington University School of Medicine, St Louis
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06937086

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Menerima pesertaFase 1
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Menerima pesertaFase 2
  • Center for Gastrointestinal Health - Fairview Heights, Belleville · 14 mi jauhnya
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07186101

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Menerima pesertaFase 2
  • KAD Clinical Research, St Louis
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07483073

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Menerima pesertaFase 3
  • Washington University School of Medicine, St Louis
Usia 2 hingga 19 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT04844606

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Menerima pesertaFase 2
  • KAD Clinical Research, St Louis
  • Specialists in Gastroenterology, St Louis
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Menerima pesertaFase 4
  • Washington University School of Medicine, St Louis
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06095128

BOOM-IBD2 Pivotal Clinical Trial

Menerima peserta
  • Gateway GI Research (Objective Health), St Louis
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT06571669

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Menerima pesertaFase 2
  • Mirador Therapeutics Selected Site, Bridgeton · 15 mi jauhnya
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 12 Mar 2026 · NCT07113522

Uji klinis Kolitis Ulseratif di kota lain

Studi lain di St. Louis

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.